Every finding on record at Compassionate Healthcare Management Group, Inc.

Based on observations, clinical record reviews, and staff interviews, the agency failed to ensure medication profiles for one (1) of twelve (12) patients (P#1) was updated to reflect current medications at the time of the comprehensive assessments. The findings include: During a home visit on 10/19/21, at approximately 11:30 a.m., with Registered Nurse (RN) AA, the surveyor reviewed P#1's clinical record for the certification period of 8/27/21 to 10/25/21. Review of the medical record revealed diagnoses that include chronic obstruction pulmonary disease, chronic respiratory with hypoxia. When comparing the medications P#1 was taking at home to the agency's current medication profile, it was determined that P#1's medications did not match the agency's medication profile. 1. Patient #1 was taking Combivent Respimat 20-100 micrograms (MCG) solution pharmacy label dated 9/15/21, scheduled to take one puff four times daily for breathing. Hospice agency medication profile revealed Combivent Respimat 20-100 mcg take on emergency as needed dated 1/16/21. There were no specified directions regarding how many puffs to take for breathing, which did not correspond to the Combivent's order. 2. Patient #1 was taking Furosemide 20 to 40 milligrams (MG) take one to two tablets oral daily for fluid retention. The medication profile dated 10/18/21, revealed that patient should take Furosemide 10mg (half tablet) oral once daily for mild edema, take 20mg (1 tablet) oral once daily for mild to moderate edema; take 30mg (one and half tablets) oral once daily for moderate to severe edema or 40mg (two tablets) oral once daily for severe edema. However, P#1's medication bottle pharmacy label dated 9/29/21, revealed Furosemide 20mg to 40mg take one or two tablets oral daily for fluid retention. On 10/19/21, at 12:22 p.m., an interview was conducted with a Registered Nurse (RN) AA, who stated she was assigned as the case manager to P#1. (RN) AA, stated that she was not aware that P#1's above listed medications did not correspond with the medication profile; and that this was the first time she would work in an hospice - it was a new area to her.

Based on observations, clinical record reviews, and staff interviews, the agency failed to ensure plan of care for one (1) of twelve (12) patients (P#1) was updated to reflect current medications at the time of the comprehensive assessments. The findings include: During a home visit on 10/19/21, at approximately 11:30 a.m., with Registered Nurse (RN) AA, the surveyor reviewed P#1's clinical record for the certification period of 8/27/21 to 10/25/21. Review of the medical record revealed diagnoses that include chronic obstruction pulmonary disease, chronic respiratory with hypoxia. When comparing the medications P#1 was taking at home to the agency's current plan of care, it was determined that P#1's medications did not match the agency's plan of care. 1. Patient #1 was taking Combivent Respimat 20-100 micrograms (MCG) solution pharmacy label dated 9/15/21, scheduled to take one puff four times daily for breathing. Hospice agency medication profile revealed Combivent Respimat 20-100 mcg take on emergency as needed dated 1/16/21. The order did not specify how many puffs to take for breathing, which did not correspond to the Combivent's order. 2. Patient #1 was taking Furosemide 20 to 40 milligrams (MG) take one to two tablets oral daily for fluid retention. The medication profile dated 10/18/21, revealed that patient should take Furosemide 10mg (half tablet) oral once daily for mild edema, take 20mg (1 tablet) oral once daily for mild to moderate edema; take 30mg (one and half tablets) oral once daily for moderate to severe edema or 40mg (two tablets) oral once daily for severe edema. However P#1's medication bottle pharmacy label dated 9/29/21, revealed Furosemide 20mg to 40mg take one or two tablets oral daily for fluid retention. On 10/19/21 at 12:22 p.m., an interview was conducted with a Registered Nurse (RN) AA, who stated she was assigned as the case manager for P#1. (RN) AA, stated that she was not aware that P#1's above listed medications did not correspond with the medication profile; and that this was the first time she would work in an hospice - it was a new area to her.